Preparing for the Post-Brexit Clinical Supply Chain
Pharma Industry, Regulatory
For clinical trial sponsors and clinical supply vendors with research in the United Kingdom (UK) and/or the European Union (EU), changes are coming. With the UK scheduled to leave the EU on March 29, 2019, understanding how this will affect the clinical supply chain is critical to supporting ongoing research. While political negotiations are ongoing, and the exact outcome is unclear, the research industry needs to prepare now.
Related Education Resources.
All ResourcesFDA Policy for REMS Reqmts during COVID-19
Topics: Health Care, Pharma Industry, Strategic Planning
Guidance Document
Free
GCSG 2019 US Conference: Presentation and Workshop Slides
Topic: Conference
Presentation
Members
Guy Disney - European Knowledge Forum Keynote Speaker 2022
Topic: Conference
Video
Members